Egetis Therapeutics AB (OSTO:EGTX) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:EGTX Egetis Therapeutics AB OSTO:EGTX
66 GF Score
Price kr6.37
GF Value kr5.59
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Egetis Therapeutics AB Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

OSTO:EGTX
66GF Score
Egetis Therapeutics AB OSTO:EGTX
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Egetis Therapeutics AB (OSTO:EGTX) Overvalued in 2026?

Based on GuruFocus' analysis, Egetis Therapeutics AB stock appears to be overvalued. The current stock price of kr6.37 is trading 14% above its estimated GF Value™ of kr5.59. GuruFocus considers Egetis Therapeutics AB to be Modestly Overvalued.

Key valuation signals for OSTO:EGTX:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: kr5.59 vs. price of kr6.37 (14% above fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the OSTO:EGTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Egetis Therapeutics AB Business Description

Other Exchanges PDPHF:USA0ABW:UKP0F:Germany
Address Grev Turegatan 11 C, Stockholm, SWE, 114 46
Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.
66GF Score

Get the complete analysis for OSTO:EGTX

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr6.37
Price
kr5.59
GF Value